Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity

Blood

Volumn 96, Issue 5, 2000, Pages 1953-1960

  Michigami, T ^a   Shimizu, N ^a   Williams, P J ^a   Niewolna, M ^a   Dallas, S L ^a   Mundy, G R ^a   Yoneda, T ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM 45; COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN G; INTEGRIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOTOXIN; NEUTRALIZING ANTIBODY; PARATHYROID HORMONE RELATED PROTEIN; RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL;

EID: 0034284054     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.5.1953.h8001953_1953_1960     Document Type: Article

References (40)

1. Multiple myeloma
2. Myeloma bone disease
3. Evidence for the secretion of the osteoclast stimulating factor in myeloma
4. Multiple myeloma; increasing evidence for a multi-step transformation process
5. Adhesion of human myelomaderived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion
6. 7
7. The development of a model for the homing of multiple myeloma cells to human bone marrow
8. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture
9. Role of bone marrow stromal cells in the growth of human multiple myeloma
10. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells
11. Vascular cell adhesion molecule-1 and VLA-4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells
12. Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements
13. Contact between human bone marrow stromal cells and B-lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells
14. Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells
15. 1 integrin in human B cell lines derived from myeloma, leukemia or lymphoma
16. Characterization of adhesion molecules on human myeloma cell lines
17. A murine model of human myeloma bone disease
18. Animal model of human disease: Multiple myeloma
19. Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse
20. Development of an in vivo model of human multiple myeloma bone disease
21. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells
22. Production and characterization of monoclonal antibodies to parathyroid hormonerelated protein
23. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow
24. -(src) tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo
25. Differentiation of HL-60 cells into cells with the osteoclast phenotype
26. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures
27. Expression of the cell-adhesion molecule VCAM-1 by stromal cells is necessary for osteoclastogenesis
28. 1 integrin stimulate osteoclast formation in vitro
29. 1 on melanoma cells can inhibit the invasive stage of metastatic formation
30. Allele-specific inactivation ot the α4 integrin gene expression in fibrosarcoma cell lines and relevance for spontaneous metastasis
31. Differential use of very late antigen-4 and -5 integrins by hematopietic precursors and myeloma cells to adhere to transforming growth factor-β1-treated bone marrow stroma
32. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma
33. Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin
34. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients
35. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells
36. Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: A case report
37. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma
38. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
39. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteocalstogenesis-inhihitory factor and is identical to TRANCE/RANKL
40. 1-VCAM-1 interaction